Axon Enterprise (NASDAQ:AXON) Rating Lowered to Hold at Craig Hallum

Craig Hallum lowered shares of Axon Enterprise (NASDAQ:AXON) from a buy rating to a hold rating in a research report report published on Thursday, Marketbeat reports. Craig Hallum currently has $625.00 price objective on the biotechnology company’s stock.

Several other brokerages have also recently commented on AXON. Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday. Finally, Robert W. Baird upped their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $561.31.

Axon Enterprise Trading Down 9.0 %

NASDAQ AXON opened at $540.00 on Thursday. The firm has a market capitalization of $41.18 billion, a PE ratio of 139.54, a price-to-earnings-growth ratio of 5.95 and a beta of 1.05. The business’s 50-day moving average price is $622.57 and its two-hundred day moving average price is $515.53. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise has a 12 month low of $260.27 and a 12 month high of $715.99.

Insider Activity at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total value of $1,508,636.16. Following the transaction, the insider now owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. This trade represents a 1.76 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the transaction, the director now owns 24,259 shares of the company’s stock, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Fourth Dimension Wealth LLC bought a new position in Axon Enterprise during the 4th quarter valued at $30,000. Prestige Wealth Management Group LLC raised its holdings in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at about $40,000. Brooklyn Investment Group purchased a new position in Axon Enterprise during the third quarter worth about $41,000. Finally, Y.D. More Investments Ltd purchased a new position in Axon Enterprise during the fourth quarter worth about $45,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.